1. Farley HA, Pommier RF. Treatment of Neuroendocrine Liver Metastases. Surgical oncology clinics of North America. Jan 2016;25(1):217–225.
2. Spolverato G, Bagante F, Wagner D, et al. Quality of life after treatment of neuroendocrine liver metastasis. J Surg Res. Sep 2015;198(1):155–164.
3. Chamberlain RS, Canes D, Brown KT, et al. Hepatic neuroendocrine metastases: does intervention alter outcomes? Journal of the American College of Surgeons. Apr 2000;190(4):432–445.
4. Thompson GB, van Heerden JA, Grant CS, Carney JA, Ilstrup DM. Islet cell carcinomas of the pancreas: a twenty-year experience. Surgery. Dec 1988;104(6):1011–1017.
5. Chen H, Hardacre JM, Uzar A, Cameron JL, Choti MA. Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? Journal of the American College of Surgeons. Jul 1998;187(1):88–92; discussion 92–83.